Zusammenfassung
Im Umgang mit den unerwünschten Wirkungen von injizierbaren Fillern zeigt sich das Können des Behandlers. Häufige unerwünschte Wirkungen, wie Schwellungen und Hämatome, lassen sich per definitionem nicht vollständig vermeiden. Wichtig ist es, die Patienten auf diese unerwünschten Wirkungen hinzuweisen, ohne sie zu verängstigen und, falls notwendig, ein Behandlungskonzept anbieten zu können. Seltene unerwünschte Reaktionen sind schwerer zu vermeiden, weil zu den Risikofaktoren dieser Reaktionen nur wenig Evidenz vorhanden ist. Auch die Therapie ist hier schwieriger, weil viele Interventionen nicht auf ihre Wirksamkeit überprüft wurden.
Abstract
Dealing with the unwanted or adverse effects of injectable fillers shows the skill of the practitioner. Common adverse effects, such as edema and hematoma, cannot be completely avoided per se but their frequency can be reduced. It is important to inform patients of potential adverse effects without frightening them and, if necessary, to be able to offer a treatment concept. Rare adverse reactions are harder to avoid because there is little evidence on the risk factors of these reactions. The treatment is also more difficult here because many interventions have not been tested for their effectiveness.
Literatur
Alijotas-Reig J, García-GImenez V, Velthuis PJ, Niessen FB, Decates TS (2022) Inflammatory immune-mediated adverse reactions induced by COVID-19 vaccines in previously injected patients with soft tissue fillers: a case series of 20 patients. J Cosmet Dermatol 21(8):3181–3187
Beleznay K, Humphrey S, Carruthers JD, Carruthers A (2014) Vascular compromise from soft tissue augmentation: experience with 12 cases and recommendations for optimal outcomes. J Clin Aesthet Dermatol 7(9):37–43
Colon J, Mirkin S, Hardigan P, Elias MJ, Jacobs RJ (2023) Adverse events reported from Hyaluronic acid dermal filler injections to the facial region: a systematic review and meta-analysis. Cureus 15(4):e38286
De Maio M, Rzany B (2014) Injectable fillers in aesthetic medicine, 2. Aufl. Springer, Heidelberg. ISBN 978-3-642-45124‑9.
Decates TS, Sayghani F, van Loghem JA, Velthuis PJ (2022) The Dutch Hyacorp® filler catastrophe: new EU legislation will prevent this from happening again. Eur J Dermatol 32(5):584–588
Dua A, Bhardwaj B (2022) Delayed onset nodules after hyaluronic acid fillers: a case series. J Cutan Aesthet Surg 15(1):91–94
Farr C, Menzel J, Seeberger J, Schweigle B (1997) Clinical pharmacology and possible applications of hyaluronidase with reference to Hylase “Dessau”. Wien Med Wochenschr 147(15):347–355
Goodman GJ, Magnusson MR, Callan P, Roberts S, Hart S, McDonald CB, Clague M, Rudd A, Bekhor PS, Liew S, Molton M, Wallace K, Corduff N, Arendse S, Manoharan S, Shamban A, Heydenrych I, Bhatia AC, Peng P, Pavicic T, Kapoor KM, Kosenko DE (2020) A consensus on minimizing the risk of hyaluronic acid embolic visual loss and suggestions for immediate bedside management. Aesthet Surg J 40(9):1009–1021
Goodman GJ, Magnusson MR, Callan P, Roberts S, Hart S, Lin F, Rahman E, McDonald CB, Liew S, Porter C, Corduff N, Clague M (2022) Aspiration before tissue filler—an exercise in futility and unsafe practice. Aesthet Surg J 42(1):89–101
Goodman GJ, McDonald CB, Lim A, Porter CE, Deva AK, Magnusson M, Patel A, Hart S, Callan P, Rudd A, Roberts S, Wallace K, Bekhor P, Clague M, Williams L, Corduff N, Wines N, Al-Niaimi F, Fabi SG, Studniberg HM, Smith S, Tsirbas A, Arendse S, Ciconte A, Poon T (2023) Making sense of late tissue nodules associated with hyaluronic acid injections. Aesthet Surg J 43(6):NP438–NP448
Kato JM, Matayoshi S (2022) Visual loss after aesthetic facial filler injection: a literature review on an ophthalmologic issue. Arq Bras Oftalmol 85(3):309–319
Lavikainen LI, Guyatt GH, Kalliala IEJ, Cartwright R, Luomaranta AL, Vernooij RWM, Tähtinen RM, Tadayon Najafabadi B, Singh T; ROTBIGGS Investigators; Pourjamal N, Oksjoki SM, Khamani N, Karjalainen PK, Joronen KM, Izett-Kay ML, Haukka J, Halme ALE, Ge FZ, Galambosi PJ, Devereaux PJ, Cárdenas JL, Couban RJ, Aro KM, Aaltonen RL, Tikkinen KAO. Risk of thrombosis and bleeding in gynecologic noncancer surgery: systematic review and meta-analysis. Am J Obstet Gynecol. 2023 Dec 10:S0002–9378(23)02117‑8.
Park KE, Mehta P, Kherani F, Lee WW, Woodward JA, Foster JA, Zhang-Nunes S (2023) Response of 21 hyaluronic acid fillers to recombinant human hyaluronidase. Plast Reconstr Surg Glob Open 11(12):e5457
Pérez-Pérez L, García-Gavín J, Wortsman X, Santos-Briz Á (2017) Delayed Adverse Subcutaneous Reaction to a New Family of Hyaluronic Acid Dermal Fillers With Clinical, Ultrasound, and Histologic Correlation.Dermatol Surg 43(4):605–608
Pérez-Ruiz C, Barabash-Neila R, Zulueta-Dorado T, Conejo-Mir Sánchez J (2019) Adverse granulomatous reaction to silicone filler treated with methotrexate. Dermatol Surg 45(3):489–492
Philibert F, Gras-Champel V, Chaby G et al (2020) Eruptive granuloma after injection of Ellansé® successfully treated using methotrexate. Ann Dermatol Venereol 147(8–9):525–529
Rzany B, DeLorenzi C (2015) Understanding, avoiding, and managing severe filler complications. Plast Reconstr Surg 36(5 Suppl):196S–203S
Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R (1999) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet 353(9171):2190–2194
Rzany B, Bachmann F, Nast A (2013) Adverse reaction to fillers. Diagnosis and management. Hautarzt 64(3):163–170
Rzany B, Converset-Viethel S, Hartmann M, Larrouy JC, Ribé N, Sito G, Noize-Pin C (2019) Efficacy and safety of 3 new resilient Hyaluronic acid fillers, crosslinked with decreased BDDE, for the treatment of dynamic wrinkles: results of an 18-month, randomized controlled trial versus already available Comparators. Dermatol Surg 45(10):1304–1314
Sharad J (2022) Hyaluronic acid filler injection for localized scleroderma—case report and review of literature on filler injections for localized scleroderma. Clin Cosmet Investig Dermatol 15:1627–1637
Signorini M, Liew S, Sundaram H, De Boulle KL, Goodman GJ, Monheit G, Wu Y, Trindade de Almeida AR, Swift A, Vieira Braz A, Global Aesthetics Consensus Group (2016) Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg 137(6):961e–971e
Sprott H, Fleck C (2023) Hyaluronic acid in rheumatology. Pharmaceutics 15(9):2247
Vasconcelos-Berg R, Izidoro JF, Wenz F, Müller A, Navarini AA, Sigrist RMS (2023) Doppler ultrasound-guided filler injections: useful tips to integrate ultrasound in daily practice. Aesthet Surg J 43(7):773–783
Verner I, Naveh HP, Bertossi D (2019) Treatment of injection-induced ecchymoses with light/laser-assisted technology. Dermatol Ther 32(3):e12861
Wilde CL, Gupta A, Lee S, Ezra DG (2023) Tear trough filler using the three-point tangent technique: lessons from 1452 tear trough applications. Plast Reconstr Surg Glob Open 11(6):e5060
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
B. Rzany gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Rzany, B. Häufige und seltene Nebenwirkungen von injizierbaren Fillern. hautnah (2024). https://doi.org/10.1007/s12326-024-00629-x
Accepted:
Published:
DOI: https://doi.org/10.1007/s12326-024-00629-x